These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6144510)

  • 21. [The neurochemical profile of the dorsal hippocampus and the antiaversive effects of anxiolytics in different models of anxiety in rats].
    Talalaenko AN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1993; 43(3):621-6. PubMed ID: 8103252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiety but not arousal increases 5-hydroxytryptamine release in the rat ventral hippocampus in vivo.
    Rex A; Voigt JP; Fink H
    Eur J Neurosci; 2005 Sep; 22(5):1185-9. PubMed ID: 16176361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anxiolytic-like effects induced by medial prefrontal cortex inhibition in rats submitted to the Vogel conflict test.
    Resstel LB; Souza RF; Guimarães FS
    Physiol Behav; 2008 Jan; 93(1-2):200-5. PubMed ID: 17884112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Behavioral models of anxiety in animals].
    Thiebot MH
    Encephale; 1983; 9(4 Suppl 2):167B-176B. PubMed ID: 6144511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
    Howells FM; Russell VA
    Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain mechanisms associated with therapeutic actions of benzodiazepines: focus on neurotransmitters.
    Snyder SH; Enna SJ; Young AB
    Am J Psychiatry; 1977 Jun; 134(6):662-5. PubMed ID: 17304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of exposure to a predator on behaviour and serotonergic neurotransmission in different brain regions of C57bl/6N mice.
    Beekman M; Flachskamm C; Linthorst AC
    Eur J Neurosci; 2005 May; 21(10):2825-36. PubMed ID: 15926930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent progress in development of psychotropic drugs (1)--Anti-anxiety drugs].
    Kudo Y; Kudo T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):75-86. PubMed ID: 7796324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug mechanisms in anxiety.
    Bourin M; Hascoët M
    Curr Opin Investig Drugs; 2001 Feb; 2(2):259-65. PubMed ID: 11816841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One for all or one for one: does co-transmission unify the concept of a brain galanin "system" or clarify any consistent role in anxiety?
    Barrera G; Echevarria DJ; Poulin JF; Laforest S; Drolet G; Morilak DA
    Neuropeptides; 2005 Jun; 39(3):289-92. PubMed ID: 15944024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoamines and acetylcholine in primate cerebral cortex: what anatomy tells us about function.
    Smiley JF
    Rev Bras Biol; 1996 Dec; 56 Su 1 Pt 1():153-64. PubMed ID: 9394498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neurology of anxiety.
    Trimble MR
    Postgrad Med J; 1988; 64 Suppl 2():22-6. PubMed ID: 3064063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA; Fish EW; De Bold JF; De Almeida RM
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal stress alters the negative correlation between neuronal activation in limbic regions and behavioral responses in rats exposed to high and low anxiogenic environments.
    Mairesse J; Viltart O; Salomé N; Giuliani A; Catalani A; Casolini P; Morley-Fletcher S; Nicoletti F; Maccari S
    Psychoneuroendocrinology; 2007 Aug; 32(7):765-76. PubMed ID: 17666188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New molecular targets for antianxiety interventions.
    Gorman JM
    J Clin Psychiatry; 2003; 64 Suppl 3():28-35. PubMed ID: 12662131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limbic mechanisms of anxiolytics acting on 5-HT receptors.
    Płaźnik A; Kostowski W; Stefański R
    Pol J Pharmacol; 1994; 46(5):473-7. PubMed ID: 7894537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infralimbic D1 receptor agonist effects on spontaneous novelty exploration and anxiety-like defensive responding in CD-1 mice.
    Wall PM; Blanchard RJ; Markham C; Yang M; Blanchard DC
    Behav Brain Res; 2004 Jun; 152(1):67-79. PubMed ID: 15135970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.